Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1)Disease stage: cT1-3N1-2M0 at diagnosis (prior to NACT) as per AJCC 8th edition 2)Estrogen receptor (ER) and progesterone receptor (PR)and HER2 status evaluated on primary tumour 3)Received standard NACT as per local guidelines and become cN0, Axilla imaging to assess response to NACT (as per local guidelines) 4)Undergo dual tracer sentinel lymph node biopsy (SLNB) after NACT
Exclusion criteria
Exclusion criteria: 1)Bilateral synchronous invasive breast cancer, 2)Sentinel node biopsy prior to NACT, Previous 3)Axillary nodal surgery on the same body side
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Rate of arm lymphedema 1 year after surgeryTimepoint: 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| Axillary recurrence rate, Recurrence free interval, Axillary recurrence free interval, Other locoregional recurrence rates (breast or chest wall recurrence), Rate of distant metastasisTimepoint: 1,2 and 5 years | — |
Countries
India
Contacts
All India Institute of Medical Sciences, New Delhi